American International Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,470
| Closed | -$1.89M | – | 348 |
|
|
2024
Q1 | $1.89M | Sell |
5,470
-16
| -0.3% | -$5.26K | 0.01% | 1026 |
|
|
2023
Q4 | $1.77M | Sell |
5,486
-40
| -0.7% | -$12.5K | 0.01% | 1036 |
|
|
2023
Q3 | $1.98M | Sell |
5,526
-251
| -4% | -$96.8K | 0.01% | 959 |
|
|
2023
Q2 | $2.19M | Sell |
5,777
-1,148
| -17% | -$467K | 0.01% | 946 |
|
|
2023
Q1 | $3.32M | Buy |
6,925
+15
| +0.2% | +$7.02K | 0.02% | 831 |
|
|
2022
Q4 | $2.91M | Buy |
6,910
+947
| +16% | +$382K | 0.02% | 856 |
|
|
2022
Q3 | $2.49M | Sell |
5,963
-201
| -3% | -$100K | 0.02% | 885 |
|
|
2022
Q2 | $3.05M | Sell |
6,164
-154
| -2% | -$80.2K | 0.02% | 853 |
|
|
2022
Q1 | $3.56M | Sell |
6,318
-179
| -3% | -$108K | 0.02% | 877 |
|
|
2021
Q4 | $4.91M | Sell |
6,497
-49
| -0.7% | -$36.7K | 0.02% | 808 |
|
|
2021
Q3 | $4.88M | Sell |
6,546
-2,722
| -29% | -$2.04M | 0.03% | 792 |
|
|
2021
Q2 | $5.97K | Sell |
9,268
-283
| -3% | -$172K | 0.02% | 779 |
|
|
2021
Q1 | $5.46K | Sell |
9,551
-2,166
| -18% | -$1.28M | 0.02% | 797 |
|
|
2020
Q4 | $6.83K | Sell |
11,717
-104
| -0.9% | -$59.2K | 0.03% | 647 |
|
|
2020
Q3 | $6.09M | Sell |
11,821
-456
| -4% | -$231K | 0.03% | 577 |
|
|
2020
Q2 | $5.54M | Sell |
12,277
-34,842
| -74% | -$15.4M | 0.03% | 605 |
|
|
2020
Q1 | $16.5M | Sell |
47,119
-2,026
| -4% | -$745K | 0.09% | 157 |
|
|
2019
Q4 | $18.2M | Buy |
49,145
+195
| +0.4% | +$68.7K | 0.07% | 185 |
|
|
2019
Q3 | $16.3M | Buy |
48,950
+1,895
| +4% | +$618K | 0.07% | 208 |
|
|
2019
Q2 | $14.7M | Sell |
47,055
-1,238
| -3% | -$371K | 0.06% | 242 |
|
|
2019
Q1 | $14.8M | Buy |
48,293
+7,229
| +18% | +$1.95M | 0.06% | 232 |
|
|
2018
Q4 | $9.54M | Buy |
41,064
+316
| +0.8% | +$84.8K | 0.04% | 358 |
|
|
2018
Q3 | $12.8M | Sell |
40,748
-34
| -0.1% | -$10.6K | 0.04% | 302 |
|
|
2018
Q2 | $11.8M | Buy |
40,782
+326
| +0.8% | +$90K | 0.04% | 301 |
|
|
2018
Q1 | $10.1M | Sell |
40,456
-1,386
| -3% | -$353K | 0.04% | 388 |
|
|
2017
Q4 | $9.99M | Buy |
41,842
+696
| +2% | +$169K | 0.03% | 433 |
|
|
2017
Q3 | $9.14M | Sell |
41,146
-1,423
| -3% | -$320K | 0.03% | 432 |
|
|
2017
Q2 | $9.63M | Buy |
42,569
+1,005
| +2% | +$219K | 0.03% | 401 |
|
|
2017
Q1 | $8.29M | Buy |
41,564
+1,505
| +4% | +$290K | 0.03% | 481 |
|
|
2016
Q4 | $7.3M | Buy |
40,059
+138
| +0.3% | +$23.5K | 0.03% | 516 |
|
|
2016
Q3 | $6.54M | Sell |
39,921
-512
| -1% | -$77.7K | 0.03% | 536 |
|
|
2016
Q2 | $5.78M | Sell |
40,433
-505
| -1% | -$72K | 0.02% | 578 |
|
|
2016
Q1 | $5.6M | Buy |
40,938
+87
| +0.2% | +$11.4K | 0.02% | 677 |
|
|
2015
Q4 | $5.67M | Sell |
40,851
-930
| -2% | -$129K | 0.02% | 660 |
|
|
2015
Q3 | $5.61M | Sell |
41,781
-70
| -0.2% | -$10.1K | 0.02% | 657 |
|
|
2015
Q2 | $6.3M | Sell |
41,851
-9
| -0% | -$1.29K | 0.03% | 634 |
|
|
2015
Q1 | $5.66M | Buy |
41,860
+1,132
| +3% | +$140K | 0.02% | 711 |
|
|
2014
Q4 | $4.91M | Sell |
40,728
-1,006
| -2% | -$116K | 0.02% | 759 |
|
|
2014
Q3 | $4.73M | Buy |
41,734
+607
| +1% | +$71.9K | 0.02% | 765 |
|
|
2014
Q2 | $4.92M | Sell |
41,127
-798
| -2% | -$97.4K | 0.02% | 776 |
|
|
2014
Q1 | $5.37M | Sell |
41,925
-6
| -0% | -$769 | 0.03% | 692 |
|
|
2013
Q4 | $5.18M | Sell |
41,931
-888
| -2% | -$108K | 0.03% | 683 |
|
|
2013
Q3 | $5.03M | Sell |
42,819
-398
| -0.9% | -$46.9K | 0.03% | 664 |
|
|
2013
Q2 | $4.85M | Buy |
+43,217
| New | +$5.07M | 0.03% | 650 |
|
Other funds holding BIO
VAM
